These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 8391705)
1. Measles immunization strategies for an epidemiologically heterogeneous population: the Israeli case study. Agur Z; Danon YL; Anderson RM; Cojocaru L; May RM Proc Biol Sci; 1993 May; 252(1334):81-4. PubMed ID: 8391705 [TBL] [Abstract][Full Text] [Related]
2. Pulse mass measles vaccination across age cohorts. Agur Z; Cojocaru L; Mazor G; Anderson RM; Danon YL Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11698-702. PubMed ID: 8265611 [TBL] [Abstract][Full Text] [Related]
3. Prevention of measles in Israel: short- and long-term intervention strategies. Tulchinsky TH Isr J Med Sci; 1991 Jan; 27(1):22-9. PubMed ID: 1995496 [TBL] [Abstract][Full Text] [Related]
4. Measles containment in Israel. Slater PE Isr J Med Sci; 1991 Jan; 27(1):19-21. PubMed ID: 1995495 [TBL] [Abstract][Full Text] [Related]
5. [The impact of immunization against measles on epidemiology of measles in Poland]. Janaszek W Przegl Epidemiol; 1998; 52(4):413-25. PubMed ID: 10321085 [TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel. Levine H; Zarka S; Ankol OE; Rozhavski V; Davidovitch N; Aboudy Y; Balicer RD Hum Vaccin Immunother; 2015; 11(6):1400-5. PubMed ID: 25891446 [TBL] [Abstract][Full Text] [Related]
7. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Sugerman DE; Barskey AE; Delea MG; Ortega-Sanchez IR; Bi D; Ralston KJ; Rota PA; Waters-Montijo K; Lebaron CW Pediatrics; 2010 Apr; 125(4):747-55. PubMed ID: 20308208 [TBL] [Abstract][Full Text] [Related]
8. Measles epidemiology and outbreak response immunization in a rural community in Peru. Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877 [TBL] [Abstract][Full Text] [Related]
9. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE). Zilber N; Rannon L; Alter M; Kahana E Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828 [TBL] [Abstract][Full Text] [Related]
10. First 5 years of measles elimination in southern Africa: 1996-2000. Biellik R; Madema S; Taole A; Kutsulukuta A; Allies E; Eggers R; Ngcobo N; Nxumalo M; Shearley A; Mabuzane E; Kufa E; Okwo-Bele JM Lancet; 2002 May; 359(9317):1564-8. PubMed ID: 12047966 [TBL] [Abstract][Full Text] [Related]
11. Pediatric measles cases by residence status in Tel Aviv, Israel. Leventer-Roberts M; Sheffer R; Salama M; Nuss N; Rahmani S; Kornriech T; Mor Z Vaccine; 2020 Aug; 38(36):5773-5778. PubMed ID: 32690425 [TBL] [Abstract][Full Text] [Related]
12. [Epidemiology and prevention of measles in the United States: 30 years of vaccination]. Chauvin P Rev Epidemiol Sante Publique; 1995; 43(1):61-71. PubMed ID: 7892518 [TBL] [Abstract][Full Text] [Related]
13. Measles immunity in Israeli young adults: effects of second immunization at 18 years of age. Olsha M; Mendelson E; Shohat T; Cohen D; Duvdevani P; Lerman Y; Danon YL Isr J Med Sci; 1994 Aug; 30(8):596-9. PubMed ID: 8045739 [TBL] [Abstract][Full Text] [Related]
14. Measles, mumps and rubella: control by vaccination. van Druten JA; de Boo T; Plantinga AD Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777 [TBL] [Abstract][Full Text] [Related]
15. Measles and mathematics: "control or eradication?". Kenya PR East Afr Med J; 1990 Dec; 67(12):856-63. PubMed ID: 2083520 [TBL] [Abstract][Full Text] [Related]
16. Costs and benefits of a second measles inoculation of children in Israel, the West Bank, and Gaza. Ginsberg GM; Tulchinsky TH J Epidemiol Community Health; 1990 Dec; 44(4):274-80. PubMed ID: 2126028 [TBL] [Abstract][Full Text] [Related]
17. The status of measles after five years of mass vaccination in the USSR. Burgasov PN; Andzaparidze OG; Popov VF Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384 [TBL] [Abstract][Full Text] [Related]
18. Measles control in developing and developed countries: the case for a two-dose policy. Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe. Mahomva AI; Moyo IM; Mbengeranwa LO Cent Afr J Med; 1997 Sep; 43(9):254-6. PubMed ID: 9509644 [TBL] [Abstract][Full Text] [Related]
20. Measles incidence before and after supplementary vaccination activities--Lusaka, Zambia, 1996-2000. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Jun; 50(24):513-6. PubMed ID: 11432675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]